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formed during heat sterilization may exert a more adverseHeat sterilization of peritoneal dialysis solutions influences
effect than glucose itself on ingestive behavior, and that aingestive behavior in non-uremic rats.
reduction of the concentration of GDPs in the PD solutionBackground. The appetite inhibitory effect of glucose-based
using filter sterilization or a low pH value in the PD solutionperitoneal dialysis (PD) solutions may be due to glucose as
during heat sterilization may improve food intake.such, or the hyperosmolality of the PD solution, or an effect
of glucose degradation products (GDPs) formed in the PD
solution during heat sterilization. This was studied in an experi-
mental appetite model in rat.
A large proportion of patients treated with continuousMethods. The effect of different experimental PD solutions
ambulatory peritoneal dialysis (CAPD) are malnour-on ingestive behavior was investigated in non-uremic rats
equipped with an implanted intraoral (i.o.) cannula through ished [1–3]. Inadequate food intake and anorexia are
which a 1 mol/L sucrose solution was infused during tests. The contributing factors, and this may be in part due to ure-
amount of intake was recorded at 30 min after rats were infused mia and persistent uremic toxicity due to under-dialysisintraperitoneally (IP) with 30 mL of different solutions. This
[1, 4]. However, loss of appetite also may be secondarymethod allowed an accurate and reproducible analysis of i.o.
and due to abdominal distension by the dialysate andintake. The experimental PD solutions tested included (1)
glucose based PD solutions with different glucose concentra- absorption of glucose from the dialysate [1, 5]. Thus, the
tions, sterilized by heat or microbiological filter, (2) glucose- conventional glucose-based heat-sterilized peritoneal di-
and mannitol-based PD solutions with the same osmolality, alysis solutions, with a high concentration of glucosesterilized by heat or microbiological filter; and (3) glucose
(13.6 to 38.6 g/L), may contribute to anorexia. In chronicbased PD solutions, using different pH values (pH 3.0, pH 5.5
peritoneal dialysis, the patients may be exposed to 50 toor pH 7.4) during heat sterilization.
Results. Following IP infusion of solutions, (1) the i.o. intake 100 kg of glucose per year. Glucose is not an inert osmotic
was significantly inhibited by glucose based, heat sterilized PD agent but a nutrient that can contribute to as much as
solutions and the degree of appetite suppression was related
one third of the total energy intake, especially in CAPDto the concentration of dialysate glucose in a dose-dependent
patients with high peritoneal permeability [2, 6]. Like-way; (2) the i.o. intake was significantly less suppressed by
filter sterilized than by heat sterilized glucose-based solutions; wise, glucose-based peritoneal dialysis (PD) solutions
(3) the i.o. intake was significantly less following the IP infusion may contribute to hyperglycemia, hyperinsulinemia, hy-
of glucose-based than following the mannitol-based heat steri- perlipidemia and obesity [7]. In addition, other factors
lized solutions; however, i.o. intake did not differ between the
in the PD solutions such as pH, and type and concentra-glucose-based and mannitol-based filter sterilized solutions;
tion of buffer (in commercial solution usually 35 to 40and (4) furthermore, the degree of suppression of i.o. intake
induced by glucose-based PD solutions was influenced by the mmol/L of lactate) also may contribute to hypophagia.
pH value during heat sterilization. The lower the pH of the Increasing evidence from several in vitro and in vivo
PD solution during heat sterilization, the higher the i.o. intake. studies suggests that glucose degradation products (GDPs)Conclusions. The IP infusion of glucose-based heat-steri-
are formed in peritoneal dialysis fluids during heat steril-lized PD solutions inhibited food intake in this experimental
ization and storage and contribute to the cytotoxicityappetite model, and the degree of suppression depended on
the concentration of dialysate glucose and the pH of the solu- and bioincompatibility of PD solutions [8–10]. The accu-
tion during heat sterilization. The results suggest that GDPs mulation of GDPs in the dialysis fluid seen as a browning
of the fluid can be visualized by ultraviolet absorbance
and can be quantified by high performance liquid chro-Key words: intraoral food intake, pH, glucose, mannitol, dialysate,
filter sterilization, heat sterilization, appetite and PD. matography (HPLC) analysis [11, 12]. GDPs are small
molecular weight products, and include aldehydes and 2002 by the International Society of Nephrology
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Table 1. Characteristics of different peritoneal dialysis solutionsother compounds such as methylglyoxal and 3-desoxy-
glucosone; however, the full spectrum of various GDPs Mannitol Buffer
Glucose based based controlgenerated during heat sterilization of glucose-based PD
Lactate mmol/L 40 40 40solutions is still not known [11, 12]. Glucose degradation
Sodium mmol/L 132 132 132is reduced at low pH during heat sterilization and during
Calcium mmol/L 1.25 1.25 1.25
storage of PD solutions, and is enhanced in the presence Magnesium mmol/L 0.25 0.25 0.25
Chloride mmol/L 95 95 95of catalyzing substances such as lactate, calcium, and
pH 3.0, 5.5, or 7.4 5.5 5.5magnesium [13, 14]. GDPs in PD fluids may have many
Osmotic agent % 1.36, 2.27 or 3.86 1.36 or 3.86 0
adverse effects such as abdominal pain or discomfort Osmolarity mOsm/L 346 or 396 or 484 348 or 486 246
Sterilization Heat or filter Heat or filter Heatduring infusion, inhibition of cell proliferation, impair-
ment of inflammatory cell function, cytotoxicity, and pro-
motion of the formation of advanced glycation end prod-
ucts (AGEs) in the peritoneum [8, 15, 16]. However, the
possible effect of GDPs on appetite has not been studied lowed three weeks of recovery after surgery. The Animal
Ethical Committee of Karolinska Institutet at Huddingepreviously.
In an experimental appetite model in the rat, we have University Hospital approved the study.
previously shown that the high lactate and glucose con-
Measurement of ingestive behaviorcentration in the PD solutions may inhibit appetite ap-
parently more than pH and volume of the infused solu- Prior to the formal experiments, rats were given a
series of training for two weeks initially until the rate oftion during PD [17–19]. However, the possible separate
effects of glucose in PD solution on appetite caused intraoral (i.o.) intake had stabilized [19, 20]. Pellets were
removed at 07.00 hours and replaced after testing. Ani-by hypertonicity, absorption of glucose, and effects of
breakdown products of glucose were not analyzed in mals were tested for sucrose ingestion at 13.00 hours
(one hour after the strong lights were switched off, butprevious studies. The present study used an experimental
appetite model in the rat to investigate the impact on using indirect weak light for observation of the test).
During the test, the animals were placed in a circularappetite of (1) dialysate glucose concentration, (2) dialy-
sate hypertonicity, (3) heat sterilization of PD solutions, (35 cm diameter) Plexiglas arena and had their i.o.
cannula connected to a peristaltic pump (Alitea xv;and (4) pH in PD solutions during heat sterilization.
Ventur Alitea, Stockholm, Sweden), which delivered 1
mol/L of sucrose solution at an infusion rate of 1 mL/
METHODS
min. The duration of i.o. intake ended by the time the
Experimental appetite model animal passively let the solution drip from its mouth.
The i.o. infusion was interrupted for 30 seconds beforeMale Wistar rats (Mo¨llega˚rd Breeding Laboratories,
Ejby, Denmark) weighing 310 to 330 g and having free restarting the infusion. If the rats did not drip the solution
out within one minute, the infusion was continued andaccess to water and pellets, were maintained in individual
cages in air conditioned, temperature controlled 22C interrupted again for 30 seconds when the animal dripped
out the solution. This procedure was repeated until thecolony rooms in which the lights were off between noon
and midnight. Since darkness is an important factor for criterion, the rejection of the solution within one minute
after a 30 second interruption of the infusion, was ful-the normal ingestive behavior of the rat, the rats were
tested (see below) during this period. The methods have filled. Most rats stopped ingesting the solution within
the first minutes after having rejected it once.been described in detail previously [20].
Briefly, all surgery was performed under pentobarbital
Preparation of experimental peritoneal dialysisanesthesia (60 mg/kg IP; Mebumal; Nordic, Stockholm,
solutions and buffer solutionsSweden). The rat was placed in a stereotaxic frame and
an incision was made in the midline of the scalp. Three All solutions tested in these studies were made in our
laboratory and had the same concentrations of electro-screws were fixed in the skull to maintain the intraoral
tube. A 5 cm long PE-100 tubing was then placed be- lytes (Table 1). Solutions tested included glucose-based
PD solutions (containing 1.36%, 2.27% or 3.86% glu-tween the cheek and gum at a point slightly anterolateral
to the first upper molar on the side of the mouth. The cose, lactate 40 mmol/L, pH 5.5), mannitol-based PD
solutions (containing 1.36%, 3.86% mannitol, lactate 40tubing was advanced subcutaneously with the distal end
of the tubing protruding above the surface of the skull, mmol/L, pH 5.5) and lactate buffer solution (containing
lactate 40 mmol/L, without glucose, pH 5.5). The solu-while a 9 mm piece of stainless steel tubing was inserted
within the roof of the mouth, between the cheek and tions were either sterilized using a bacterial filter (Sterile
0.22m; Millipore S.A., Molsheim, France) or using heatgum. Dental cement was used to cover and fix the area
between the screws and cannula. The animals were al- (121 C, 45 min). In experiment 5, glucose-based PD
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solutions were sterilized with heat at pH 3.0, pH 5.5 and
pH 7.4, and were then adjusted to neutral pH using
sodium hydroxide before the IP infusion.
Experiments on ingestive behavior
The i.o. intake was measured 30 minutes after IP infu-
sion of the test solutions. The i.o. infusion delivered the
sucrose solution (1 mol/L) at the speed of 1 mL/min.
For each experiment, the rats served as their own con-
trols, using (except for experiment 3) the lactate buffered
solution without glucose as the control solution.
Experiment 1: Effect of heat-sterilized glucose-based
PD solutions. Eight rats (N  8 for each solution) were Fig. 1. Impact of glucose-based heat sterilized peritoneal dialysis (PD)
given an IP infusion with 30 mL of glucose-based heat- solutions on intraoral (i.o.) intake of sucrose. The i.o. intake in rats
(N  8) differed (P  0.05; ANOVA analysis) following IP infusionsterilized PD solutions (1.36%, 2.27% or 3.86% glucose)
with glucose based PD 1.36%, 2.27% and 3.86% solutions and controland control solution (lactate buffered solution without solution (lactate buffer without glucose). All solutions were heat steri-
glucose), respectively. The rats were tested in random lized (121 C, 45 min).
order on four consecutive days.
Experiment 2: Comparison of heat-sterilized and filter-
sterilized glucose-based PD solutions. Twenty-four rats
were randomly divided into three groups (1.36%, 2.27% Data analysis
or 3.86%). The rats (N  8 for each glucose concentra-
The results are expressed as mean  SD and analyzedtion group) were given an IP infusion with 30 mL of
using the paired t test for comparison between twofilter sterilized or heat sterilized PD solutions, and tested
groups and ANOVA for comparison between three orin random order on two consecutive days
more groups with the aid of the Statview statistical pro-Experiment 3: Comparison of filter-sterilized mannitol-
gram (SAS Institute, Inc., Cary, NC, USA) for a personal
based and glucose-based PD solutions. Sixteen rats were
computer.
randomly divided into two groups (1.36% or 3.86%).
The rats (N 8 for each group) were treated with 30 mL
1.36% glucose or 1.36% mannitol based filter-sterilized RESULTS
solutions respectively, using the lactate buffered solution There was a significant decrease in i.o. intake following
without glucose as the control, and were tested in random the IP infusion of glucose-based heat-sterilized PD solu-
order on three consecutive days. This test was repeated tions compared with the control buffer solution (Fig. 1).
using the 3.86% glucose or 3.86% mannitol-based filter The i.o. intake was inversely related to the dialysate
solutions. concentration of glucose (Fig. 1).
Experiment 4: Comparison of heat-sterilized mannitol- The i.o. intake was less reduced following the i.p. infu-
and glucose-based PD solutions. Sixteen rats were ran- sion of the filter-sterilized PD solution than after infusion
domly divided into two groups (1.36% or 3.86%). The with the heat-sterilized PD solutions for each of the
rats (N  8 for each group) were given 30 mL 1.36% different glucose (1.36%, 2.27% and 3.86%) PD solu-
glucose-based or mannitol-based heat-sterilized solu- tions (Fig. 2).
tions, respectively, using the lactate buffered solution There were no significant differences in i.o. intake
without glucose as the control, and were tested in random between the IP infusion of glucose-based and mannitol-
order on three consecutive days. This test was repeated based filter-sterilized 1.36 and 3.86% solutions, although
using 3.86% glucose-based or mannitol-based heat-steri- both the glucose-based and mannitol-based 3.86% solu-
lized solutions. tions resulted in significantly lower i.o. intake than the
Experiment 5: Effect of pH during heat sterilization. buffer control solution (Fig. 3). However, there were
Twenty-four rats were randomly divided into three significant differences in i.o. intake following the IP infu-
groups (1.36%, 2.27% or 3.86%). The rats (N  8 for sion of glucose-based and mannitol-based heat-sterilized
each group) were given 30 mL 1.36% glucose based PD PD solutions for both the 1.36% and 3.86% solutions
solutions, heat sterilized at pH 3.0, pH 5.5 and pH 7.4, (Fig. 4), and there were also significant differences in i.o.
respectively, using the filter-sterilized buffer solution as intake between infusion with 1.36% and 3.86% glucose-
a control. The solutions were tested in random order on based and mannitol-based heat-sterilized solutions on
four consecutive days. This test was repeated in the same the one hand, and, on the other hand, the buffer control
solution. These results suggest indirectly that GDPs in-way using 2.27% and 3.86% glucose solutions.
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Fig. 2. Effects of heat-sterilized ( ) and filter-sterilized () PD solu-
tions on intraoral intake of sucrose. The i.o. intake differed (P  0.05)
between rats (mean SD, N 8) receiving filter sterilized PD solutions
and rats (N  8) receiving heat sterilized PD 1.36%, 2.27% and 3.86%
Fig. 4. Effects of control (), glucose-based ( ), and mannitol-basedsolutions glucose, respectively.
( ) heat-sterilized PD solutions on intraoral intake of sucrose. The i.o.
intake in rats (mean  SD, N  8) differed between the glucose-based
or mannitol-based 1.36% and 3.86% PD solutions and the buffer control
solution. Glucose-based and mannitol-based heat-sterilized 1.36% and
3.86% PD solutions differed in their impact on i.o. intake. aSignificant
difference (P  0.05) between the buffer control solution and the other
two solutions; bsignificant difference (P  0.05) between the mannitol-
and glucose-based solutions.
Fig. 3. Effects of control (), glucose-based ( ) and mannitol-based
() filter-sterilized PD solutions on intraoral intake of sucrose. The
i.o. intake in rats (mean  SD, N  8) was significantly reduced (P 
0.05) following IP infusion of 3.86% glucose and 3.86% mannitol based
solutions compared with the control solution (lactate buffer without
glucose), but there were no significant differences between the 1.36%
mannitol-based, 1.36% glucose-based PD solutions and the buffer solu-
tion. The i.o. intake did not differ between the mannitol based and
glucose based 1.36% and 3.86% PD solutions, respectively.
Fig. 5. Effects of pH of PD solution during heat sterilization on in-
traoral intake of sucrose. The i.o. intake (mean  SD) in rats (N  8
in each group) receiving glucose-based 1.36%, 2.27% and 3.86% PD
solutions that were heat-sterilized at different pH values [() control;
( ) pH 3.0; ( ) pH 5.5; () pH 7.4], using the filter-sterilized bufferduced by the heat sterilization may be involved in appe- solution as control, was influenced by pH during heat sterilization.
tite inhibition, and also that the hypertonicity may play There were significant differences among the different pH values (pH
3.0, pH 5.5, pH 7.4) in the 1.36%, 2.27% and 3.86% glucose-baseda more important role than glucose in this experimental
solutions. The higher the pH value of the solution was during the heatsetting. sterilization, the lower the intraoral intake the solution induced.
Furthermore, the i.o. intake was significantly and ap-
parently step-wise reduced after the infusion of glucose
based solutions that had been heat sterilized using differ-
DISCUSSIONent pH (but were normalized to neutral pH prior to
Glucose is still the most commonly used osmotic agentinfusion). The pH value during sterilization had a similar
in PD solutions although alternative osmotic agents (ico-impact for the 1.36%, 2.27% and 3.86% solutions, al-
dextrin and amino acids) have recently been introduced.though the reduction of i.o. intake with higher pH during
Glucose is a main source of energy in the human body,sterilization was more marked for the 3.86% solution
and thus glucose in itself in physiologic concentration(Fig. 5). Thus, the suppression of i.o. intake was posi-
can hardly be considered toxic; however, the high con-tively related to the pH in the solution during heat steril-
ization: the higher the pH, the lower the i.o. intake. centration of glucose in PD solutions has several biologi-
Zheng et al: Heat sterilization solutions and appetite 1451
cal side effects such as growth inhibition of cultured cells reduce the caramelization of glucose, which otherwise
would turn the fluid brownish, and in standard PD fluids[21]. Furthermore, since glucose, especially d-glucose,
is not a stable compound, it can undergo a variety of the pH is therefore usually set at 5.0 to 5.5 before steril-
ization. Lower pH during heat sterilization results in lessspontaneous degradation reactions in vivo, resulting in
the formation of a variety of reaction products that are formation of GDPs. For example, when the d-glucose
concentration was 3.86%, 324 mol/L 3-deoxyglucosonepresent in healthy subjects and in higher concentrations
in uremic patients [22, 23]. Accelerated glucose break- (3-DG) was formed under standard sterilization condi-
tions (pH 5.5). On the other hand, when the 3.86% glu-down also can take place in vitro, and during heat steril-
ization of the dialysis fluid, the formation of glucose cose PD fluid was heat sterilized at pH 3, which can be
achieved in a two-chamber bag, 3-DG concentration wasdegradation products (GDPs) is highly dependant on
conditions such as temperature, duration of sterilization, reduced to 42 mol/L [22].
We therefore prepared glucose based PD solutionsglucose concentration and pH value [12, 23]. GDPs are
toxic, and several investigations of the toxicity of GDPs that were heat sterilized at pH 3.0, 5.5 and 7.4. The pH
value of these solutions was corrected to neutral pHin PD solutions have demonstrated an effect of GDPs
on the function of cells in the peritoneum [22, 24]. before instillation intraperitoneally to avoid any possible
effect of pH as such on appetite. The results showed thatOur previous study, using the same in vivo experimen-
tal appetite rat model as in the current study, found that the amount of i.o. intake was inversely related to the
pH value of PD solutions during heat sterilization: thea pH-neutral, bicarbonate/lactate buffered PD solution
with a low concentration of GDPs resulted in less inhibi- higher the pH of the solution during heat sterilization,
the stronger the appetite inhibition. This suggests ation of appetite than a conventional low pH, lactate-
buffered PD solution with high concentration of GDPs strong impact of GDPs on appetite.
Mannitol and glucose have almost the same molecular[17, 18]. We also showed that the lesser effect on appetite
of the former solution was partially due to a lower con- weight, but mannitol is more stable during heat steriliza-
tion [28, 29], and therefore was utilized (as an isoosmolarcentration of lactate in this solution. However, the possi-
ble roles of glucose and GDPs have not previously been control) to compare the effect of isoosmolar glucose-
based and mannitol-based PD solutions on appetite. Ourinvestigated.
In the present experiments, using the same experimen- results demonstrated that there was no significant differ-
ence between glucose-based and mannitol-based PD so-tal appetite model, we focused on the effects of glucose
and glucose degradation on ingestive behavior. Firstly, lutions using filter sterilization, although both glucose-
based and mannitol-based filter sterilized solutions sup-glucose-based heat-sterilized PD solutions (made in our
laboratory) were tested using different concentrations pressed appetite compared with the buffer control solu-
tion. Thus, the osmolality of the PD solution may influ-of glucose. The results show that heat-sterilized PD solu-
tions suppress food intake, and that the degree of appe- ence appetite, and this effect appears to be similar with
glucose and mannitol. In contrast, a significant differencetite inhibition is proportionate to the concentration of
glucose. Thus, glucose itself or its breakdown products, was found between glucose-based and mannitol-based
PD solutions if both were heat sterilized, suggesting anor both, are involved in the process of inhibition of food
intake during PD. impact of GDPs. In addition, we noted that the mannitol
solution was colorless while the glucose solution had aIn order to investigate the possible separate role of
GDPs in appetite inhibition, we then compared the ef- brown color after heat sterilization. This indicates indi-
rectly that glucose breakdown products formed duringfects of filter-sterilized PD solutions with heat-sterilized
PD solutions on ingestive behavior. The results showed heat sterilization contributed to hypophagia. On the
other hand, glucose-based and mannitol-based filter-that the rats given heat-sterilized PD solutions consumed
a smaller volume of i.o. sucrose than rats given filter sterilized PD solutions inhibited appetite to the same
degree compared with the control buffer solution, sug-sterilized solutions. Although we did not measure the
GDPs of the dialysate, it seems likely that degradation gesting that hyperosmolality also was involved in sup-
pression of appetite during the short intraperitonealof glucose during heat sterilization of PD solutions con-
tributed to the suppression of ingestive behavior. dwell.
Lower pH, higher glucose concentration and the re-It is conceivable that this appetite suppression is re-
lated to the rapid uptake of glucose, GDPs and lactate moval of catalyzing substances such as calcium and mag-
nesium during sterilization are known to minimize thein the portal circulation, resulting in high concentrations
of absorbed substances in the splanchnic area, and subse- cytotoxic glucose breakdown [12, 14]. In the two-com-
partment bag or three-chamber bag that are now avail-quent stimulation of hepatic glucoreceptors and secre-
tion of cholecystokinin-8, glucagon-like peptide 1, insulin able for PD fluids, the high concentration of glucose in
one compartment can be separated from the catalyzingand other mediators of appetite suppression [25–27].
Heat sterilization has to be performed at a low pH to substances such as calcium and magnesium during steril-
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5. Balaskas EV, Rodela H, Oreopoulos DG: Effects of intraperito-ization, and this can minimize generation of GDPs
neal infusion of dextrose and amino acids on the appetite of rabbits.
[14, 30]. The biocompatibility of these fluids previously Perit Dial Int 13(Suppl 2):S490–S498, 1993
was reported to be improved with regards to basal cyto- 6. Grodstein GP, Blumenkrantz MJ, Kopple JD, et al: Glucose
absorption during continuous ambulatory peritoneal dialysis. Kid-toxicity, inflammatory response, and concentration of
ney Int 19:564–567, 1981
GDPs. In the clinic, the use of the new PD fluids pro- 7. Morrison G: Metabolic effects of continuous ambulatory perito-
duced in a two-compartment bag has been shown to neal dialysis. Annu Rev Med 40:163–172, 1989
8. Wieslander AP, Deppisch R, Svensson E, et al: In vitro biocom-reduce pain during infusion and longitudinal studies have
patibility of a heat-sterilized, low-toxic, and less acidic fluid forshown signs of improved peritoneal viability such as an peritoneal dialysis. Perit Dial Int 15:158–164, 1995
increase in the dialysate concentration of cancer antigen 9. Wieslander AP, Kjellstrand PT, Rippe B: Heat sterilization of
glucose-containing fluids for peritoneal dialysis: Biological conse-125, a marker of mesothelial cell mass [31, 32]. Whereas
quences of chemical alterations. Perit Dial Int 15(Suppl):S52–S59,most previous studies were focused on the local effects 1995; discussion pp S59–S60
of PD fluids on the peritoneal cells, the present studies 10. Ho-dac-Pannekeet MM, Weiss MF, de Waart DR, et al: Analysis
of non-enzymatic glycosylation in vivo: Impact of different dialysissuggest that the bioincompatibility of heat-sterilized PD
solutions. Perit Dial Int 19(Suppl 2):S68–S74, 1999solutions also might have a systemic impact on food 11. Nilsson-Thorell CB, Muscalu N, Andren AH, et al: Heat steril-
intake and thus on nutrition. However, the possible clini- ization of fluids for peritoneal dialysis gives rise to aldehydes. Perit
Dial Int 13:208–213, 1993cal relevance of this finding has not been studied to date.
12. Wieslander A, Forsback G, Svensson E, et al: Cytotoxicity, pH,In summary, glucose-based heat-sterilized PD solu- and glucose degradation products in four different brands of PD
tions apparently inhibit ingestive behavior more than the fluid. Adv Perit Dial 12:57–60, 1996
13. Cappelli G, Bandiani G, Cancarini GC, et al: Low concentrationsglucose-based filter-sterilized PD solution, the suppres-
of glucose degradation products in peritoneal dialysis fluids andsion of intake being proportional to the concentration their impact on biocompatibility parameters: Prospective cross-
of dialysate glucose and inversely related to the pH value over study with a three-compartment bag. Adv Perit Dial 15:238–
242, 1999in the PD solution during heat sterilization. This suggests
14. Cooker LA, Luneburg P, Faict D, et al: Reduced glucose degrada-that appetite in PD patients might be improved if the tion products in bicarbonate/lactate-buffered peritoneal dialysis
dialysate concentration of GDPs were reduced by modi- solutions produced in two-chambered bags. Perit Dial Int 17:373–
378, 1997fying the method of sterilization, by lowering the pH
15. Henderson IS: Composition of peritoneal dialysis solutions: Po-value during heat sterilization, and by separating the
tential hazards. Blood Purif 7:86–94, 1989
different compounds during sterilization. New PD solu- 16. Topley N, Mackenzie R, Petersen MM, et al: In vitro testing
of a potentially biocompatible continuous ambulatory peritonealtions with low concentrations of GDPs (and with low
dialysis fluid. Nephrol Dial Transplant 6:574–581, 1991lactate and neutral pH) may be beneficial with regards
17. Zheng ZH, Sederholm F, Anderstam B, et al: Acute effects of
to reduced appetite inhibition, and therefore may con- peritoneal dialysis solutions on appetite in non-uremic rats. Kidney
Int 60:2392–2398, 2001tribute to an improved nutritional status of patients un-
18. Zheng Z, Anderstam B, Sederholm F, et al: Less inhibition ofdergoing peritoneal dialysis.
appetite with bicarbonate based than with lactate based peritoneal
dialysis. Perit Dial Int (accepted for publication)
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